Insiders · LEXX

LEXX insider transactions

Lexaria Bioscience Corp. (LEXX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for LEXX

• 39d
  SEC Form 4 filed by Bunka Christopher

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 270d
  Director Bunka Christopher bought $25,241 worth of shares (27,500 units at $0.92) (SEC Form 4)

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 270d
  Director Mckechnie William Edward bought $4,532 worth of shares (5,000 units at $0.91), increasing direct ownership by 38% to 18,191 units (SEC Form 4)

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 270d
  President & CSO Docherty John Martin bought $4,989 worth of shares (5,376 units at $0.93) (SEC Form 4)

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 270d
  Secretary Carle Vanessa bought $682 worth of shares (750 units at $0.91) (SEC Form 4)

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 270d
  Chief Executive Officer Christopher Richard bought $13,641 worth of shares (15,000 units at $0.91), increasing direct ownership by 30% to 65,000 units (SEC Form 4)

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 344d
  SEC Form 4 filed by Chief Executive Officer Christopher Richard

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 344d
  SEC Form 4 filed by Director Bunka Christopher

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 345d
  SEC Form 4 filed by Secretary Carle Vanessa

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 345d
  SEC Form 4 filed by President Docherty John Martin

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 345d
  SEC Form 4 filed by Chief Financial Officer Shankman Michael Elliot

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 345d
  SEC Form 4 filed by Director Bhullar Baljinder

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 345d
  SEC Form 4 filed by Director Baxter Nicholas W

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 345d
  SEC Form 4 filed by Director Reese Albert L Jr

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 345d
  SEC Form 4 filed by Director Mckechnie William Edward

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 465d
  New insider Bhullar Baljinder claimed ownership of 13,000 shares (SEC Form 3)

  3 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 471d
  Director Bunka Christopher was granted 100,000 units of Restricted Stock Award, increasing direct ownership by 37% to 373,543 units (SEC Form 4)

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 509d
  Chief Executive Officer Christopher Richard bought $118,392 worth of shares (50,000 units at $2.37) (SEC Form 4)

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 571d
  SEC Form 3 filed by new insider Shankman Michael Elliot

  3 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 598d
  SEC Form 3 filed by new insider Christopher Richard

  3 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 621d
  Director Turkel Catherine C. bought $5,008 worth of shares (1,600 units at $3.13), increasing direct ownership by 107% to 3,100 units (SEC Form 4)

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 633d
  Secretary Carle Vanessa sold $10,268 worth of shares (2,567 units at $4.00), closing all direct ownership in the company (SEC Form 4)

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 635d
  SEC Form 4 filed by Director Reese Albert L Jr

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 635d
  SEC Form 4 filed by Director Turkel Catherine C.

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 635d
  SEC Form 4 filed by Director Baxter Nicholas W

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 635d
  SEC Form 4 filed by Director Mckechnie William Edward

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 711d
  Carle Vanessa exercised 2,500 shares at a strike of $1.15, increasing direct ownership by 3,731% to 2,567 units (SEC Form 4)

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 716d
  SEC Form 4 filed by Carle Vanessa

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 716d
  SEC Form 4 filed by Turkel Catherine C.

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 716d
  SEC Form 4 filed by Baxter Nicholas W

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 716d
  SEC Form 4 filed by Mckechnie William Edward

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 716d
  SEC Form 4 filed by Reese Albert L Jr

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 716d
  SEC Form 4 filed by Bunka Christopher

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 716d
  SEC Form 4 filed by Docherty John Martin

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 772d
  SEC Form 3 filed by new insider Cabatuan Nelson

  3 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 907d
  SEC Form 4 filed by Carle Vanessa

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 909d
  SEC Form 4 filed by Docherty John Martin

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 909d
  SEC Form 4 filed by Bunka Christopher

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 1006d
  SEC Form 4 filed by Baxter Nicholas W

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 1006d
  SEC Form 4 filed by Mckechnie William Edward

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 1006d
  SEC Form 4 filed by Reese Albert L Jr

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 1006d
  SEC Form 4 filed by Turkel Catherine C.

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 1154d
  SEC Form 4: Turkel Catherine C. bought $4,267 worth of shares (1,500 units at $2.84)

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 1285d
  SEC Form 4: Downey Gregory bought $253 worth of shares (121 units at $2.09), increasing direct ownership by 7% to 1,954 units (Amendment)

  4/A - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 1285d
  SEC Form 4: Bunka Christopher bought $78,397 worth of shares (38,500 units at $2.04) (Amendment)

  4/A - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 1286d
  SEC Form 4: Downey Gregory was granted 121 shares, increasing direct ownership by 7% to 1,954 units

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 1291d
  SEC Form 4 filed by Mckechnie William Edward

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 1291d
  SEC Form 4 filed by Reese Albert L Jr

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 1291d
  SEC Form 4 filed by Turkel Catherine C.

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 1291d
  SEC Form 4: Bunka Christopher was granted 38,500 shares

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 1291d
  SEC Form 4 filed by Baxter Nicholas W

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 1328d
  SEC Form 4 filed by Turkel Catherine C.

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 1328d
  SEC Form 3 filed by new insider Turkel Catherine C.

  3 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 1336d
  SEC Form 4 filed by Carle Vanessa

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 1336d
  SEC Form 4 filed by Docherty John Martin

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 1336d
  SEC Form 4 filed by Bunka Christopher

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 1336d
  SEC Form 4 filed by Downey Gregory

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 1432d
  SEC Form 4: Reese Albert L Jr was granted 5,000 shares, increasing direct ownership by 85% to 10,917 units

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 1433d
  SEC Form 4: Reese Albert L Jr was granted 1,799 shares, increasing direct ownership by 44% to 5,917 units

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)
• 1438d
  SEC Form 4: Reese Albert L Jr was granted 3,201 shares, increasing direct ownership by 349% to 4,118 units

  4 - Lexaria Bioscience Corp. (0001348362) (Issuer)